VXRT - MCAP CO - Vaxart, Inc.

Vaxart, Inc. (VXRT) is implementing robotic lines to produce tablet vaccines, eliminating human error and reducing costs. The team consists of top scientists striving to create painless medicine. Currently, Vaxart, Inc. (VXRT) relies on external investments and grants as its products undergo clinical trials. This price chart on GURU.Markets, where the metric stands at , confirms the current stage of business development.

Market capitalization reflects the aggregate value of all outstanding shares as determined by the market in real time. This calculation allows for an assessment of the business scale and its investment attractiveness relative to competitors. Analyzing the total value of a company's shares helps identify periods of speculative growth or fundamental impairment. For Vaxart, Inc. (VXRT), this indicator is volatile due to the absence of stable revenue, as the valuation depends exclusively on the prospects for the commercialization of oral vaccines.